|
Volumn 28, Issue 12, 2014, Pages 1205-1206
|
Comment on: "perispinal etanercept for post-stroke neurological and cognitive dysfunction: Scientific rationale and current evidence"
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ETANERCEPT;
OPIATE;
PARACETAMOL;
IMMUNOGLOBULIN G;
NEUROPROTECTIVE AGENT;
TUMOR NECROSIS FACTOR RECEPTOR;
ACRODYNIA;
ACUTE LIVER FAILURE;
CEREBROVASCULAR ACCIDENT;
CHRONIC PAIN;
CLINICAL TRIAL (TOPIC);
COGNITIVE DEFECT;
HABITUATION;
HEALTH CARE QUALITY;
HEALTH INSURANCE;
HUMAN;
INFORMATION PROCESSING;
LETTER;
LIFE CYCLE;
LOW BACK PAIN;
MORPHINE ADDICTION;
NEUROIMAGING;
NEUROLOGIC DISEASE;
PARKINSON DISEASE;
PLACEBO EFFECT;
PRIORITY JOURNAL;
REIMBURSEMENT;
SYSTEMATIC ERROR;
ANIMAL;
COGNITION DISORDERS;
COMPLICATION;
STROKE;
ANIMALS;
COGNITION DISORDERS;
HUMANS;
IMMUNOGLOBULIN G;
NEUROPROTECTIVE AGENTS;
RECEPTORS, TUMOR NECROSIS FACTOR;
STROKE;
|
EID: 84922070898
PISSN: 11727047
EISSN: 11791934
Source Type: Journal
DOI: 10.1007/s40263-014-0211-1 Document Type: Letter |
Times cited : (4)
|
References (8)
|